Table 2.
The top five miRNAs identified by BLNIMDA to be associated with four important diseases
| Disease | Rank | miRNA | Evidence | Causality |
|---|---|---|---|---|
| Lung Neoplasms | 1 | hsa-mir-21 | miRCancer; HMDDv3.2 | YES |
| 2 | hsa-mir-155 | miRCancer; HMDDv3.2 | YES | |
| 3 | hsa-mir-146a | miRCancer; HMDDv3.2 | NO | |
| 4 | hsa-mir-17 | miRCancer; HMDDv3.2 | YES | |
| 5 | hsa-mir-34a | miRCancer; HMDDv3.2 | YES | |
| Breast Neoplasms | 1 | hsa-mir-21 | miRCancer; HMDDv3.2 | YES |
| 2 | hsa-mir-155 | miRCancer; HMDDv3.2 | YES | |
| 3 | hsa-mir-17 | miRCancer; HMDDv3.2 | YES | |
| 4 | hsa-mir-146a | miRCancer; HMDDv3.2 | YES | |
| 5 | hsa-mir-34a | miRCancer; HMDDv3.2 | YES | |
| Gastric Neoplasms | 1 | hsa-mir-148a | miRCancer; HMDDv3.2 | YES |
| 2 | hsa-mir-23a | miRCancer; HMDDv3.2 | YES | |
| 3 | hsa-mir-370 | miRCancer; HMDDv3.2 | YES | |
| 4 | hsa-mir-429 | miRCancer; HMDDv3.2 | YES | |
| 5 | hsa-mir-21 | miRCancer; HMDDv3.2 | YES | |
| Colon Neoplasms | 1 | hsa-mir-145 | miRCancer; HMDDv3.2 | YES |
| 2 | hsa-mir-17 | HMDDv3.2 | YES | |
| 3 | hsa-mir-21 | miRCancer; HMDDv3.2 | YES | |
| 4 | hsa-mir-126 | miRCancer; HMDDv3.2 | YES | |
| 5 | hsa-mir-155 | miRCancer; HMDDv3.2 | YES |